Why Attend?


  • Discover new reimbursement models which are impacting market access
  • Stay abreast of important Market Access trends and updates from across the globe
  • Hear from leading international HTA agencies
  • Learn from case studies on demonstrating product value
  • Understand the payers’ perspective
  • Discuss how to generate, apply and present ‘real world’ evidence to maximise patient access
  • Analyse and compare pricing and partnering models
  • Gain best practice insights for market access of high value and orphan drugs in the multi speaker focus day
  • Leverage evidence planning and payer strategy for optimum pricing, market access and launch
  • Source solutions at the exhibition
  • Network with pioneers, influencers and innovators and return to your company with new ideas and relationships

Who Attends?



“It was a very good networking experience and interesting to see people like Thomas Mueller and NICE officials participate in the discussions with industry.”

Patient Services Manager, Shire Pharmaceuticals